PGK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.828600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.860800E-01
Normal-vs-Stage2
2.525600E-01
Normal-vs-Stage3
6.136400E-01
Normal-vs-Stage4
3.264200E-01
Stage1-vs-Stage2
9.773600E-01
Stage1-vs-Stage3
4.610800E-01
Stage1-vs-Stage4
7.628200E-01
Stage2-vs-Stage3
3.841200E-01
Stage2-vs-Stage4
6.579200E-01
Stage3-vs-Stage4
4.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.944800E-01
Normal-vs-AfricanAmerican
1.771600E-01
Normal-vs-Asian
2.431800E-01
Caucasian-vs-AfricanAmerican
1.898000E-01
Caucasian-vs-Asian
6.838600E-01
AfricanAmerican-vs-Asian
6.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.009400E-01
Normal-vs-Female
2.661400E-01
Male-vs-Female
7.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.272400E-01
Normal-vs-Age(41-60Yrs)
4.41540000000185E-05
Normal-vs-Age(61-80Yrs)
3.683000E-01
Normal-vs-Age(81-100Yrs)
3.146800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.305200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.419600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.426400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.500800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.713400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.419000E-01
Normal-vs-Daily Drinker
3.170200E-01
Normal-vs-Weekly Drinker
3.913400E-01
Normal-vs-Occasional Drinker
2.935200E-03
Normal-vs-Social Drinker
2.090000E-01
Non Drinker-vs-Daily Drinker
6.260200E-01
Non Drinker-vs-Weekly Drinker
9.162400E-01
Non Drinker-vs-Occasional Drinker
3.905800E-02
Non Drinker-vs-Social Drinker
8.725400E-01
Daily Drinker-vs-Weekly Drinker
7.776000E-01
Daily Drinker-vs-Occasional Drinker
8.375700E-02
Daily Drinker-vs-Social Drinker
7.720000E-01
Weekly Drinker-vs-Occasional Drinker
6.628100E-02
Weekly Drinker-vs-Social Drinker
9.743000E-01
Occasional Drinker-vs-Social Drinker
5.017700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.847400E-01
Normal-vs-Grade 2
9.431200E-01
Normal-vs-Grade 3
6.891600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.831700E-02
Grade 1-vs-Grade 3
1.083940E-02
Grade 1-vs-Grade 4
8.847400E-01
Grade 2-vs-Grade 3
2.630200E-01
Grade 2-vs-Grade 4
9.431200E-01
Grade 3-vs-Grade 4
6.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.891200E-01
Normal-vs-NonDiabetic
2.593800E-01
Diabetic-vs-NonDiabetic
4.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.460300E-02
Normal-vs-NoPancreatitis
3.188000E-01
Pancreatitis-vs-NoPancreatitis
4.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.752800E-01
Normal-vs-N1
2.734800E-01
N0-vs-N1
2.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.214610E-01
Normal-vs-TP53-NonMutant
7.321400E-01
TP53-Mutant-vs-TP53-NonMutant
2.47840000000554E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
